alexa Posterior Reversible Encephalopathy Syndrome after a First Injection of Cyclophosphamide: A Case Report

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Posterior Reversible Encephalopathy Syndrome after a First Injection of Cyclophosphamide: A Case Report

Posterior reversible encephalopathy syndrome (PRES) is a clinical radiological syndrome which could be induced by pre-eclampsia, transplantation, autoimmune disease (systemic lupus erythematosus, Wegener’s granulomatosis, systemic sclerosis), abrupt arterial hypertension (which is probably one of the most important), impaired renal function or drugs (anticalcineurin, chemotherapie). Some atypical cases were also reported in a weightlifter patient after an intensive gym session or as a rare association with a polyarteritis nodosa. Renal disease seems to be a risk factor of PRES, as seen in many case reports of PRES in patients, in particular in pediatric population, with acute glomerulonephritis, lupus nephritis or, nephrotic syndrome or small vessel vasculitis.

Citation: Scailteux LM, Hudier L, Renaudineau E, Jego P, Drouet T (2015) Posterior Reversible Encephalopathy Syndrome after a First Injection of Cyclophosphamide: A Case Report. J Pharmacovigilance 3: 163.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger